California State Teachers Retirement System (CalSTRS)’s Orchestra BioMed OBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,893
Closed -$8.1K 3118
2025
Q1
$8.1K Hold
1,893
﹤0.01% 2827
2024
Q4
$7.57K Buy
1,893
+210
+12% +$1.13K ﹤0.01% 2934
2024
Q3
$8.65K Hold
1,683
﹤0.01% 2917
2024
Q2
$13.7K Buy
1,683
+218
+15% +$1.26K ﹤0.01% 2765
2024
Q1
$7.72K Sell
1,465
-933
-39% -$6.32K ﹤0.01% 2949
2023
Q4
$21.9K Sell
2,398
-817
-25% -$5.58K ﹤0.01% 2885
2023
Q3
$28K Sell
3,215
-9,301
-74% -$62.5K ﹤0.01% 2921
2023
Q2
$87.6K Buy
+12,516
New +$190K ﹤0.01% 2699

Other funds holding OBIO

California State Teachers Retirement System (CalSTRS)'s OBIO Position: Q2 2025 in Review

California State Teachers Retirement System (CalSTRS) sold out of Orchestra BioMed (OBIO) in Q2 2025, closing a stake of 1,893 shares — an estimated $8.1K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in OBIO in Q2 2023 and held it in 8 quarters. The position peaked at $87.6K in Q2 2023. 59 funds tracked by Wall St. Rank hold OBIO as of Q2 2025.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Orchestra BioMed position as of Q2 2025 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 1,893 Orchestra BioMed shares in Q2 2025, an estimated $8.1K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Orchestra BioMed in Q2 2023 and held it in 8 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Orchestra BioMed position peaked at $87.6K in Q2 2023.
  • 59 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2025.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2025, filed 14 Aug 2025.